Differential functional effects of two 5-HT4 receptor isoforms in adult cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 39, Issue 2, 2005, Pages 335-344

  Castro, Liliana ^a   Mialet Perez, Jeanne ^a   Guillemeau, Aurélie ^a   Stillitano, Francesca ^d   Zolk, Oliver ^b   Eschenhagen, Thomas ^c   Lezoualc'h, Frank ^a   Bochet, Pascal ^a   Fischmeister, Rodolphe ^a  

^a INSERM   (France)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

5 HT4 receptor; Adenovirus; Cyclic AMP; HL 1 cell line; L type Ca2+ current; Rat cardiomyocytes; Serotonin

Indexed keywords

1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; ADENYLATE CYCLASE; CALCIUM CHANNEL L TYPE; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 4 B RECEPTOR; SEROTONIN 4 D RECEPTOR; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CELL ISOLATION; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVATION; EXPRESSION VECTOR; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; VIRUS STRAIN;

ADENOVIRIDAE; ADENYLATE CYCLASE; ANIMALS; CALCIUM CHANNELS, L-TYPE; HUMANS; INDOLES; ISOPROTERENOL; MICE; MYOCYTES, CARDIAC; PERTUSSIS TOXIN; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, SEROTONIN, 5-HT4; SULFONAMIDES;

ADENOVIRIDAE; ANIMALIA; ANURA; CAVIA PORCELLUS; MURINAE; ORYCTOLAGUS CUNICULUS; SUS SCROFA;

EID: 22244465519     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.04.009     Document Type: Article

References (44)

1. 4 receptor ligands: applications and new prospects J. Med. Chem. 46 2003 319 344
2. f in human isolated atrial myocytes Cardiovasc. Res. 40 1998 516 522
3. 4 receptors Mol. Pharmacol. 41 1992 346 351
4. 4 receptor cloned from human atrium FEBS Lett. 412 1997 465 474
5. U. Jahnel, J. Rupp, R. Ertl, and H. Nawrath Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle Naunyn Schmied Arch. Pharmacol. 346 1992 482 485
6. R.G. Schoemaker, X.Y. Du, W.A. Bax, E. Bos, and P.R. Saxena 5-Hydroxytryptamine stimulates human isolated atrium but not ventricle Eur. J. Pharmacol. 230 1993 103 105
7. 4 mRNA in heart failure Naunyn Schmied Arch. Pharmacol. 370 2004 157 166
8. 4 receptors mediate arrhythmias? Trends Pharmacol. Sci. 15 1994 451 455
9. S. Yusuf, N. Al-Saady, and A.J. Camm 5-hydroxytryptamine and atrial fibrillation: how significant is this piece in the puzzle? J. Cardiovasc. Electrophysiol. 14 2003 209 214
10. 4 receptor antagonist RS-100302 in experimental atrial flutter and fibrillation Circ. 100 1999 2010 2017
11. 4 receptor isoforms produced by alternative splicing in the carboxyl terminus J. Neurochem. 70 1998 2252 2261
12. 4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain Mol. Pharmacol. 55 1999 910 920
13. 4 splice variant J. Neurochem. 74 2000 478 489
14. 4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines Br. J. Pharmacol. 129 2000 771 781
15. 4 receptor variants Neuropharmacol. 42 2002 60 73
16. 4(i) Naunyn Schmied Arch. Pharmacol. 369 2004 616 628
17. 4 receptor in the central nervous system by TaqMan real time RT-PCR Brain Res. Mol. Brain Res. 90 2001 125 134
18. 4(d) receptor splice variant stably expressed in Chinese hamster ovary cells Br. J. Pharmacol. 131 2000 827 835
19. 4 receptor splice variants: compound specificity and dual coupling with Gαs- and Gαi/o-proteins Mol. Pharmacol. 61 2002 85 96
20. 4-like receptors in mammalian atria J. Neural Transm. 34 1991 195 201
21. 4 receptor: molecular cloning and pharmacological characterization of two splice variants EMBO J. 14 1995 2806 2815
22. S. Laer, F. Remmers, H. Scholz, B. Stein, F.U. Muller, and J. Neumann Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium Br. J. Pharmacol. 123 1998 1182 1188
23. S.M. White, P.E. Constantin, and W.C. Claycomb Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function Am. J. Physiol. Heart Circ. Physiol. 286 2004 H823 H829
24. T. Rau, M. Nose, U. Remmers, J. Weil, A. Weissmuller, and K. Davia Overexpression of wild-type Gαi2 suppresses β-adrenergic signaling in cardiac myocytes FASEB J. 17 2003 523 525
25. 2+ current in rat ventricular myocytes Br. J. Pharmacol. 127 1999 65 74
26. Y.Y. Zhou, S.Q. Wang, W.Z. Zhu, A. Chruscinski, B.K. Kobilka, and B. Ziman Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology Am. J. Physiol. Heart Circ. Physiol. 279 2000 H429 H436
27. W.C. Claycomb, N.A. Lanson, B.S. Stallworth, D.B. Egeland, J.B. Delcarpio, and A. Bahinski HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte Proc. Natl. Acad. Sci. USA 95 1998 2979 2984
28. H.G. Joost, A.D. Habberfield, I.A. Simpson, A. Laurenza, and K.B. Seamon Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action Mol. Pharmacol. 33 1988 449 453
29. C. Cao, J.H. Han, S.Z. Kim, K.W. Cho, and S.H. Kim Diverse regulation of atrial natriuretic peptide secretion by serotonin receptor subtypes Cardiovasc. Res. 59 2003 360 368
30. 4 receptors present in piglet atria and sensitive to SDZ 205-557 are absent in papillary muscle Eur. J. Pharmacol. 229 1992 105 108
31. R.G. Schoemaker, X.Y. Du, W.A. Bax, and P.R. Saxena 5-Hydroxytryptamine increases contractile force in porcine right atrium but not in left ventricle Naunyn Schmied Arch. Pharmacol. 346 1992 486 489
32. 4(b) receptors have nearly identical pharmacology and are both expressed in human atrium and ventricle Naunyn Schmied Arch. Pharmacol. 363 2001 146 160
33. Ca,L in frog ventricular myocytes J. Physiol. 551 2003 239 252
34. F. Rochais, G. Vandecasteele, F. Lefebvre, C. Lugnier, H. Lum, and J.L. Mazet Negative feedback exerted by PKA and cAMP phosphodiesterase on subsarcolemmal cAMP signals in intact cardiac myocytes. An in vivo study using adenovirus-mediated expression of CNG channels J. Biol. Chem. 279 2004 52095 52105
35. J.L. Bos Epac: a new cAMP target and new avenues in cAMP research Nat. Rev. Mol. Cell Biol. 2 2003 369 377
36. M. Maillet, S.J. Robert, M. Caquevel, M. Gastineau, D. Vivien, and J. Bertoglio Cross-talk between Rap1 and Rac regulates sAPPα secretion Nat. Cell Biol. 5 2003 633 639
37. D.M. Roden Antiarrhythmic drugs: past present and future J. Cardiovasc. Electrophysiol. 14 2003 1389 1396
38. 4 receptor-mediated inotropic response to serotonin in heart failure Cardiovasc. Res. 65 2005 869 878
39. 4 receptor by site-directed mutagenesis and molecular modeling Br. J. Pharmacol. 130 2000 527 538
40. 4 receptor binding site: exploration of a hydrophobic pocket Br. J. Pharmacol. 143 2004 361 370
41. T. Namba, Y. Sugimoto, M. Negishi, A. Irie, F. Ushikubi, and A. Kakizuka Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity Nature 365 1993 166 170
42. i Circ. Res. 87 2000 705 709
43. A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure Cardiovasc. Res. 60 2003 478 487
44. R.J. Hajjar, U. Schmidt, T. Matsui, J.L. Guerrero, K.H. Lee, and J.K. Wathmey Modulation of ventricular function through gene transfer in vivo Proc. Natl. Acad. Sci. USA 95 1998 5251 5256